comparemela.com
  1. Home
  2. Live Updates
  3. Deimos Biosciences - Breaking News

Latest Breaking News On - Deimos biosciences - Page 1 : comparemela.com

G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses

- Jupiter Bioventures will Gain Exclusive Rights for the Clinical Development, Regulatory Submissions, and Commercialization of Lerociclib for Radioprotection in the US, Europe, Japan, and All Other.

Jupiter bioventuresDavid buttaroJack baileyGenor biopharmaNathaniel davidGain exclusive rights for the clinical developmentResearch triangle parkExchange commissionTherapeutics incNational medical products administrationCorporate communicationsGain exclusive rightsClinical developmentRegulatory submissionsDeimos biosciencesManaging director

G1 Therapeutics And Deimos Biosciences In License Deal For Lerociclib For Radioprotective Uses

(RTTNews) - G1 Therapeutics, Inc. (GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures,.

Genor biopharmaJupiter bioventuresTherapeutics incNational medical products administrationDeimos biosciencesDeimos biosciencePepper bio

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.